Cytodyn Inc (CYDY)

[lorbas95]

I think you have some good points.

While the FDA communicates that they want this adamantly approved, their actions speak differently, and they give their best to troll CYDY as hard as possible. Would it be better, if someone else was in charge? Who knows? Perhaps if we got a super-muscular ex-Gilead nobel-prize winning CEO that intimidated FDA reviewers by his mere presence, lol. We've got a good relationship with FDA insofar as the cancer and GvHD studies are approved rapidly and insofar as they didn't require 100 patients for combo trial etc.

Further, there is no excuse for not having the 700mg stability data ready by now, which delays BLA submission for 1 or even 1,5 months. This costs another 7.5m roughly, money CYDY does not have at this point. Moreover, it seems clear that Nader did not watch Pestell closely enough, which cost us dearly (quite understandable though - who could have suspected such a mess?).

And I agree that he shouldn't have had a bonus - not until we are OVER the finish line and SP reflects the progress. But shareholders approved it, and so be it.

At this point, we simply have to wait another five weeks to see whether the deal comes to fruition.

And let's not forget that Nader saved leronlimab from being shelved and failing (which is a huge achievent and many future patients will owe him their lives for this).